UGT1A9
MOLECULAR TARGETUDP glucuronosyltransferase family 1 member A9
UGT1A9 (UDP glucuronosyltransferase family 1 member A9) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting UGT1A9
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | diclofenac | 5.66 | 285 |
| 2 | Edaravone | 0.69 | 1 |
| 3 | scutellarein | 0.69 | 1 |
About UGT1A9 as a Drug Target
UGT1A9 (UDP glucuronosyltransferase family 1 member A9) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented UGT1A9 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
UGT1A9 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.